Literature DB >> 16638474

Systematic review of topical antimicrobial therapy for acute otitis externa.

Richard M Rosenfeld1, Michael Singer, Jared M Wasserman, Sandra S Stinnett.   

Abstract

OBJECTIVE: To determine the efficacy of topical antimicrobials for acute otitis externa. STUDY
DESIGN: Systematic review and random effects meta-analysis of randomized, controlled trials with parallel groups permitting one or more of the following comparisons: antimicrobial vs placebo, antiseptic vs antimicrobial, quinolone antibiotic vs nonquinolone antibiotic, steroid-antimicrobial vs antimicrobial, or antimicrobial-steroid vs steroid.
RESULTS: Twenty trials met inclusion criteria and 18 had data suitable for pooling. Topical antimicrobials increased absolute clinical cure rates over placebo by 46% (95% confidence interval [CI], 29% to 63%) and bacteriologic cure rates by 61% (95% CI, 46% to 76%). No significant differences were noted in clinical cure rates for other comparisons, except that steroid alone increased cure rates by 20% compared with steroid plus antibiotic (95% CI, 3% to 38%). Quinolone drops increased bacteriologic cure rates by 8% compared with nonquinolone antibiotics (95% CI, 1% to 16%), but had statistically equivalent rates of clinical cure and adverse events.
CONCLUSION: Topical antimicrobial is highly effective for acute otitis externa with clinical cure rates of 65% to 80% within 10 days of therapy. Minor differences were noted in comparative efficacy, but broad confidence limits containing small effect sizes make these of questionable clinical significance. SIGNIFICANCE: Summary estimates from the 13 meta-analyses can be used to facilitate evidence-based management recommendations and clinical practice guideline development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16638474     DOI: 10.1016/j.otohns.2006.02.013

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  12 in total

1.  Effective treatment of acute otitis externa: a comparison of steroid antibiotic versus 10% ichthammol glycerine pack.

Authors:  B L Shrestha; I Shrestha; R C M Amatya; A Dhakal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-01-01

Review 2.  Otitis externa.

Authors:  Daniel Hajioff; Samuel Mackeith
Journal:  BMJ Clin Evid       Date:  2008-06-26

3.  Comparison of Boric Acid and Combination Drug of Polymyxin, Neomycin and Hydrocortisone (polymyxin NH) in the Treatment of Acute Otitis Externa.

Authors:  Soroush Amani; Mohammad Moeini
Journal:  J Clin Diagn Res       Date:  2016-07-01

Review 4.  Otitis externa.

Authors:  Daniel Hajioff; Samuel Mackeith
Journal:  BMJ Clin Evid       Date:  2010-08-03

5.  Acute otitis externa.

Authors:  Charles Ps Hui
Journal:  Paediatr Child Health       Date:  2013-02       Impact factor: 2.253

6.  The management of otitis externa in UK general practice.

Authors:  L Pabla; M Jindal; K Latif
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-15       Impact factor: 2.503

Review 7.  Otitis Externa.

Authors:  Susanne Wiegand; Reinhard Berner; Antonius Schneider; Ellen Lundershausen; Andreas Dietz
Journal:  Dtsch Arztebl Int       Date:  2019-03-29       Impact factor: 5.594

Review 8.  Review article: Topical antibiotic treatments for acute otitis externa: Emergency care guidelines from an ear, nose and throat perspective.

Authors:  Hershil Khatri; Johnson Huang; Emily Guazzo; Craig Bond
Journal:  Emerg Med Australas       Date:  2021-09-26       Impact factor: 2.279

9.  A double-blind randomised clinical trial of the treatment of otitis externa using topical steroid alone versus topical steroid-antibiotic therapy.

Authors:  E Abelardo; L Pope; K Rajkumar; R Greenwood; D A Nunez
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06-17       Impact factor: 2.503

10.  Clinical practice guideline development manual: a quality-driven approach for translating evidence into action.

Authors:  Richard M Rosenfeld; Richard N Shiffman
Journal:  Otolaryngol Head Neck Surg       Date:  2009-06       Impact factor: 3.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.